The development of immunological factors in infants with hyperbilirubinemia - PubMed (original) (raw)

• PMID: 5410230

The development of immunological factors in infants with hyperbilirubinemia

Z Nejedlá. Pediatrics. 1970 Jan.

No abstract available

PubMed Disclaimer

Similar articles

• [The effect of exsanguinotransfusion on the development of immunological factors].
  Nejedlá Z. Nejedlá Z. Monatsschr Kinderheilkd (1902). 1966 Mar;114(3):107-10. Monatsschr Kinderheilkd (1902). 1966. PMID: 4864438 German. No abstract available.
• [The development of immunologic factors in children with hyperbilirubinemia].
  Nejedlá Z. Nejedlá Z. Monatsschr Kinderheilkd (1902). 1968 Nov;116(11):574-6. Monatsschr Kinderheilkd (1902). 1968. PMID: 4890945 German. No abstract available.
• The effect of exchange transfusion on the development of immunological factors.
  Nejedlá Z. Nejedlá Z. Vox Sang. 1967 Feb;12(2):118-31. Vox Sang. 1967. PMID: 5334504 No abstract available.
• [Conservative methods of control of hyperbilirubinemia in newborn infants (review of the literature)].
  Punchenok NA. Punchenok NA. Vopr Okhr Materin Det. 1968 May;13(5):60-3. Vopr Okhr Materin Det. 1968. PMID: 4888517 Review. Russian. No abstract available.
• [Nonspecific hyperbilirubinemia in the newborn infant].
  Klinke K. Klinke K. Kinderarztl Prax. 1966 Jun;34(6):256-62. Kinderarztl Prax. 1966. PMID: 5336329 Review. German. No abstract available.

Cited by

• The suppressive effect of continuous infusion of bilirubin on the immune response in mice.
  Síma P, Malá J, Miler I, Hodr R, Truxová E. Síma P, et al. Folia Microbiol (Praha). 1980;25(6):483-90. doi: 10.1007/BF02897214. Folia Microbiol (Praha). 1980. PMID: 7192250
• Bilirubin as a metabolic hormone: the physiological relevance of low levels.
  Creeden JF, Gordon DM, Stec DE, Hinds TD Jr. Creeden JF, et al. Am J Physiol Endocrinol Metab. 2021 Feb 1;320(2):E191-E207. doi: 10.1152/ajpendo.00405.2020. Epub 2020 Dec 7. Am J Physiol Endocrinol Metab. 2021. PMID: 33284088 Free PMC article. Review.
• Can bilirubin nanomedicine become a hope for the management of COVID-19?
  Khurana I, Allawadhi P, Khurana A, Srivastava AK, Navik U, Banothu AK, Bharani KK. Khurana I, et al. Med Hypotheses. 2021 Apr;149:110534. doi: 10.1016/j.mehy.2021.110534. Epub 2021 Feb 13. Med Hypotheses. 2021. PMID: 33640714 Free PMC article.
• The immunosuppressive effects of bilirubin.
  Vĕtvicka V, Síma P, Miler I, Bilej M. Vĕtvicka V, et al. Folia Microbiol (Praha). 1991;36(2):112-9. doi: 10.1007/BF02814488. Folia Microbiol (Praha). 1991. PMID: 1823644 Review.
• Bile pigments in emergency and critical care medicine.
  Seya M, Aokage T, Nojima T, Nakao A, Naito H. Seya M, et al. Eur J Med Res. 2022 Oct 29;27(1):224. doi: 10.1186/s40001-022-00863-0. Eur J Med Res. 2022. PMID: 36309733 Free PMC article. Review.

MeSH terms